Understanding The Impact Of Different Types Of Cholesterol


Cholesterol is a waxy substance that is needed by the body for the production of hormones, cell membranes, and vitamin D. However, too much cholesterol can lead to a buildup of plaque in the arteries, which can increase the risk of heart disease and stroke. Recent scientific studies have explored the different types of cholesterol and how they impact our health. In this informative blog, we will explore the key findings and conclusions on the cholesterol markers, including different lipid types and apoB, and provide practical tips for monitoring and managing the right cholesterol markers for optimal health and longevity.

1. Lipoproteins are not all equal

Lipoproteins are the carriers of cholesterol in the blood, and they are classified into two types: low-density lipoprotein (LDL) and high-density lipoprotein (HDL). LDL is known as the “bad” cholesterol because it carries cholesterol to the arteries, where it can build up and cause blockages. HDL, on the other hand, is known as the “good” cholesterol because it carries cholesterol away from the arteries and back to the liver, where it can be processed and eliminated from the body.

Recent studies have shown that not all LDL particles are created equal. Small, dense LDL particles are more dangerous than large, fluffy LDL particles because they can more easily penetrate the walls of the arteries and cause damage. In fact, a study published in the Journal of the American College of Cardiology found that people with high levels of small, dense LDL particles had a significantly increased risk of cardiovascular disease.

2. ApoB protein is a more accurate marker of heart health

Another important cholesterol marker is apoB, which is a protein that is found in LDL particles. Studies have shown that apoB is a better predictor of cardiovascular disease risk than LDL cholesterol levels alone. In fact, a study published in the European Heart Journal found that measuring apoB levels in addition to LDL cholesterol levels can provide a more accurate assessment of cardiovascular disease risk.

3. Other lipid markers can support diagnosis of overall risk of cardiovascular disease

In addition to LDL, HDL, and apoB, other lipid markers can provide important information about cholesterol and cardiovascular disease risk. For example, triglycerides are a type of fat that can contribute to plaque buildup in the arteries when levels are high. A study published in the Journal of the American College of Cardiology found that people with high triglyceride levels and low HDL levels had a higher risk of cardiovascular disease than people with low triglyceride levels and high HDL levels.

4. Genetics and cholesterol

Genetics play a role in cholesterol levels and some people may have what is called familial hypercholesterolemia, where they have high LDL levels due to genetic mutations. Those at risk need to get tested and seek medical management to reduce their risk of heart disease. However, lifestyle factors can also contribute to high cholesterol levels and should not be overlooked.

Furthermore, recent studies have shown that lifestyle changes can have a significant impact on cholesterol levels and cardiovascular disease risk. For example, a study published in the Journal of the American Medical Association found that a diet that is rich in fruits, vegetables, whole grains, and lean proteins can lower LDL cholesterol levels by an average of 5-10%. Regular exercise and quitting smoking can also help to lower cholesterol levels and reduce the risk of heart disease and stroke.

5. Practical tips for tracking and managing cholesterol markers

To track and manage cholesterol markers, it is recommended to get a regular lipid panel test that measures total cholesterol, LDL, HDL, and triglycerides. However, it is also important to ask about apoB testing, as it can provide additional information on heart disease risk. Lifestyle factors, such as a healthy diet, regular exercise, maintaining a healthy weight, and avoiding smoking can all contribute to healthy cholesterol levels. Additionally, some supplements like omega-3s can have a positive effect on cholesterol levels.

Conclusion

Cholesterol is an important factor in cardiovascular disease risk, but not all cholesterol is created equal. Recent studies have shown that small, dense LDL particles and apoB levels are better predictors of cardiovascular disease risk than LDL cholesterol levels alone. Additionally, lifestyle changes such as eating a healthy diet, exercising regularly, and quitting smoking can have a significant impact on cholesterol levels and reduce the risk of heart disease and stroke. If you are concerned about your cholesterol levels, talk to your healthcare provider about the best ways to monitor and manage your cholesterol markers for optimal health and longevity.

References

  1. Mensink, R.P., et al. (2003). Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. The American journal of clinical nutrition, 77(5), 1146-1155. [Link](https://academic.oup.com/ajcn/article/77/5/1146/4689811)
  1. Patrick, Rhonda. (2020). Exploring the New Science of Lipids with Dr. Ronald Krauss. FoundMyFitness Podcast.Link
    1. Hegele, R.A., et al. (2020). Apolipoprotein B in Clinical Practice: A Marker for Cardiovascular Risk. Lipids Health Dis, 19(232). [Link](https://lipidworld.biomedcentral.com/articles/10.1186/s12944-020-01387-1)
    2. Varbo, A., et al. (2013). Remnant cholesterol as a causal risk factor for ischemic heart disease. Journal of the American College of Cardiology, 61(4), 427-436. [Link](https://www.jacc.org/doi/10.1016/j.jacc.2012.08.1026)
    3. Siri-Tarino, P.W., Sun, Q., Hu, F.B., & Krauss, R.M. (2010). Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease. The American journal of clinical nutrition, 91(3), 535-546. [Link](https://academic.oup.com/ajcn/article/91/3/535/4597110)
    4. Mora, S., et al. (2009). Levels of low-density lipoprotein cholesterol, non–high-density lipoprotein cholesterol, and apolipoprotein B in future cardiovascular events. Circulation, 120(7), 502-509. [Link](https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.109.884455)
    5. Thomas, T.R., et al. (2005). Exercise and the low-density lipoprotein subclass profile in individuals with metabolic syndrome. Metabolism, 54(8), 1127-1134. [Link](https://www.metabolismjournal.com/article/S0026-0495(05)00126-1/fulltext)
    6. Patrick, Rhonda. (2019). Omega-3 Fatty Acids, Inflammation & Cardiovascular Disease. FoundMyFitness Blog.Link
      1. Lee, J., et al. (2009). Effects of smoking cessation on changes in blood lipids and body mass index: a meta-analysis. Annals of internal medicine, 150(3), 145-153. Link
  2. Di Angelantonio E, Sarwar N, Perry P, et al. Major lipids, apolipoproteins, and risk of vascular disease. JAMA. 2009;302(18):1993-2000.
  3. Walldius G, Jungner I. The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy. J Intern Med. 2006;259(5):493-519.
  4. Ridker PM, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359(21):219

Recent Posts